BCM
ANAB icon

Burrage Capital Management’s AnaptysBio ANAB Stock Holding History

Burrage Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-330,549
Closed -$4.88M – 26
2020
Q3 		$4.88M Buy
330,549
+2,435
+0.7% +$43.9K 3.85% 12
2020
Q2 		$7.33M Sell
328,114
-3,805
-1% -$69.6K 5.13% 7
2020
Q1 		$4.48M Sell
331,919
-28,181
-8% -$427K 4.41% 6
2019
Q4 		$5.85M Buy
+360,100
New +$8.52M 3.92% 9

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Burrage Capital Management's ANAB Position: Q4 2020 in Review

Burrage Capital Management sold out of AnaptysBio (ANAB) in Q4 2020, closing a stake of 330,549 shares — an estimated $4.88M sold.

Burrage Capital Management first reported a position in ANAB in Q4 2019 and held it in 4 quarters. The position peaked at $7.33M in Q2 2020. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

  • Burrage Capital Management reported no remaining AnaptysBio position as of Q4 2020 after selling out during the quarter.
  • Burrage Capital Management sold 330,549 AnaptysBio shares in Q4 2020, an estimated $4.88M.
  • Burrage Capital Management first reported a position in AnaptysBio in Q4 2019 and held it in 4 quarters.
  • Burrage Capital Management's AnaptysBio position peaked at $7.33M in Q2 2020.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on Burrage Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.